Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

‘Polypill’ improves survival rates for heart disease sufferers

10.05.2005


A ‘polypill’ made up of a combination of drugs could extend the lives of thousands of patients with coronary heart disease, say researchers at The University of Nottingham.



The study, published in the latest British Medical Journal, found that combinations of cholesterol lowering drugs (statins), aspirin and beta-blockers, which lower blood pressure, improve survival rates in high-risk patients with cardiovascular disease.

However, despite proposals in the past that these drugs, combined into a ‘polypill’ with folic acid, should be given to all patients over the age of 55, the researchers found no evidence that this would be beneficial.


This is the first large-scale, long-term trial to look at the effect of different combinations of drugs to prevent deaths of patients with heart disease.

The study, led by Professor Julia Hippisley-Cox in the University’s Centre for Population Sciences, involved more than 13,000 patients who were diagnosed with ischaemic heart disease between 1996 and 2003.

The combination of statins, aspirin and beta-blockers appeared to improve survival rates most effectively — by 83 per cent. Adding another type of blood pressure lowering drug (an angiotensin converting enzyme (ACE) inhibitor) offered no extra benefit. At 19 per cent, beta-blockers alone were the least successful. ACE inhibitors offered just a 20 per cent reduction in risk.

The data came from the QRESEARCH database, run by The University of Nottingham in collaboration with the IT software provider EMIS. QRESEARCH automatically collects real-time data from 500 GP practices (representing around eight million patients) throughout the UK. The system anonymises and uploads practices’ clinical data to a central database.

Prof Julia Hippisley-Cox | alfa
Further information:
http://www.nottingham.ac.uk

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>